Get Premium to unlock powerful stock data
NYSE:OGN (USA)  
Organon & Co logo

Organon & Co

$ 35.79 -0.0717 (-0.2%) 11:27 AM EST
P/E:
6.98
P/B:
0
Market Cap:
$ 9.03B
Enterprise V:
$ 17.50B
Volume:
248.52K
Avg Vol (2M):
1.61M
Also Trade In:
Volume:
248.52K
Market Cap $:
9.03B
PE Ratio:
6.98
Avg Vol (2-Month):
1.61M
Enterprise Value $:
17.50B
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Organon & Co
NAICS : 325412 SIC : 2834
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Description
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
Name Current Vs Industry Vs History
Cash-To-Debt 0.08
Equity-to-Asset -0.12
Debt-to-Equity -7.28
Debt-to-EBITDA 4.4
Interest Coverage 5.31
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.7
Distress
Grey
Safe
Beneish M-Score -2.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 73.92
9-Day RSI 59.37
14-Day RSI 54.35
6-1 Month Momentum % 24.16
12-1 Month Momentum % 26.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.61
Quick Ratio 1.2
Cash Ratio 0.3
Days Inventory 141.97
Days Sales Outstanding 77.06
Days Payable 192.8

Financials (Next Earnings Date:2022-08-12 Est.)

OGN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:OGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6,365
EPS (TTM) ($) 5.1
Beta 0
Volatility % 45.23
14-Day RSI 54.35
14-Day ATR ($) 1.057001
20-Day SMA ($) 35.559
12-1 Month Momentum % 26.03
52-Week Range ($) 28.42 - 39.475
Shares Outstanding (Mil) 253.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Organon & Co Filings

Document Form Filing Date
No Filing Data

Headlines

See More